These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
    Author: Shirasaka Y, Masaoka Y, Kataoka M, Sakuma S, Yamashita S.
    Journal: Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834.
    Abstract:
    In a previous study, the concentration-dependent permeability of P-glycoprotein (P-gp) substrate drugs, quinidine, verapamil, and vinblastine, in several cell monolayers with different levels of P-gp expression was analyzed kinetically to obtain fundamental parameters for P-gp-mediated transport, V(max) and K(m(app)) values. Both V(max) and K(m(app)) values of each drug were found to show linear correlations with the expression level of P-gp. These findings imply the possibility of estimating the V(max) and K(m(app)) values of P-gp substrate drugs in the in vivo intestinal membrane on the basis of the P-gp expression level. In the present study, concentration-dependent drug permeability to the rat small intestines (upper jejunum and ileum) was simulated on the basis of V(max) and K(m(app)) values of each drug estimated from the P-gp expression level in the rat small intestines. To validate the predictability of these procedures, drug permeability in the rat small intestines was measured by the in situ single-pass perfusion method. It was confirmed that simulated permeability of each drug in the rat jejunum and ileum corresponded well with permeability measured by the in situ single-pass perfusion method. This study clearly demonstrated the potential to estimate the permeability of P-gp substrate drugs in the human intestine from its P-gp expression level and thus the possibility to predict the oral absorption of those drugs.
    [Abstract] [Full Text] [Related] [New Search]